439 results on '"Eitner, Frank"'
Search Results
2. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study
3. Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution
4. Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits
5. Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease
6. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
7. Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
8. A flow cytometry approach reveals heterogeneity in conventional subsets of murine renal mononuclear phagocytes
9. The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats
10. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology
11. BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor
12. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology
13. Role of Platelet-Derived Growth Factor-CC in Capillary Rarefaction in Renal Fibrosis
14. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)
15. Clinical Predictors of Individual Cognitive Fluctuations in Patients Undergoing Hemodialysis
16. Sirolimus in renal transplant recipients with malignancies in Germany
17. Platelet-Derived Growth Factor (PDGF)-C Neutralization Reveals Differential Roles of PDGF Receptors in Liver and Kidney Fibrosis
18. TRPM2 Plays a Minor Role in AKI and Kidney Fibrosis
19. Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits
20. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
21. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
22. Models of IgA nephropathy
23. Analyse des calcifications chez les patients ayant une atteinte coralliforme de l’aorte
24. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney
25. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study
26. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort
27. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney.
28. Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
29. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
30. The PDGF family in renal fibrosis
31. Littoral Cell Angioma of the Spleen Mimicking Posttransplantation Lymphoma in a 63-Year-Old Renal Transplant Patient
32. Immune Modulating Therapy for IgA Nephropathy: Rationale and Evidence
33. Model-based correction of the influence of body position on continuous segmental and hand-to-foot bioimpedance measurements
34. HYPERTENSION: EXPERIMENTAL
35. Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database
36. Pharmacological inhibition of Vanin-1 is not protective in models of acute and chronic kidney disease
37. Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis
38. Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage
39. Pilot study of non-contrast-enhanced MRI vs. ultrasound in renal transplant recipients with acquired cystic kidney disease: a prospective intra-individual comparison
40. Determinants of Successful Use of Sirolimus in Renal Transplant Patients
41. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
42. Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils
43. Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
44. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms
45. Contributors
46. Acquired Cystic Kidney Disease and Malignant Neoplasms
47. The German Chronic Kidney Disease (GCKD) study: design and methods
48. Improving hand hygiene compliance rates in the haemodialysis setting: more than just more hand rubs
49. Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
50. Current Therapy for IgA Nephropathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.